General Information of the Compound
Compound ID
CP0391995
Compound Name
US9187480, ethyl N-{1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]piperidin-4-yl}carbamate
    Show/Hide
Synonyms
Diphenyl purine derivative 4
PMID26161824-Compound-153
    Show/Hide
Structure
Formula
C25H24Cl2N6O2
Molecular Weight
511.413
Canonical SMILES
CCOC(=O)NC1CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C25H24Cl2N6O2/c1-2-35-25(34)30-17-11-13-32(14-12-17)23-21-24(29-15-28-23)33(18-9-7-16(26)8-10-18)22(31-21)19-5-3-4-6-20(19)27/h3-10,15,17H,2,11-14H2,1H3,(H,30,34)
    Show/Hide
InChIKey
YNFZOBCSHAKXPA-UHFFFAOYSA-N
Physicochemical Property
logP
5.5042
Rotatable Bonds
5
Heavy Atom Count
35
Polar Areas
85.17
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 72712999
ChEMBL ID
CHEMBL2436754
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 3.57 nM
   TI
   LI
   LO
   TS
Protein ID: PT00834, Cannabinoid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 426 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Diphenyl purine derivative 4 )
Drug Name Diphenyl purine derivative 4
Company RESEARCH TRIANGLE INSTITUTE
Indication
Obesity
Patented
Target(s)
Cannabinoid receptor 1 (CB1)
Antagonist